Long-term survival of real-world advanced melanoma patients treated with targeted therapy

被引:0
|
作者
Ismail, R. [1 ]
de Boer, A. [2 ]
van Dartel, M. [2 ]
Hilarius, D. [3 ]
van Zeijl, M. [4 ]
van den Eertwegh, F. [5 ]
Aarts, M. [6 ]
Van den Berkmortel, F. [7 ]
Boers-Sonderen, M. [8 ]
de Groot, J. W. B. [9 ]
Haanen, J. B. A. G. [10 ]
Hospers, G. A. P. [11 ]
Kapiteijn, E. [12 ]
Piersma, D. [13 ]
van Rijn, R. [14 ]
Suijkerbuijk, K. P. M. [15 ]
ten Tije, A. J. [16 ]
Van der Veldt, A. A. M. [17 ]
Vreugdenhil, G. [18 ]
Wouters, M. [1 ]
机构
[1] DICA Dutch Inst Clin Auditing, Leiden, Netherlands
[2] Med Evaluat Board, Oncol, Utrecht, Netherlands
[3] Rodekruis Ziekenhuis Beverwijk, Clin Pharm, Beverwijk, Netherlands
[4] Leiden Univ Med Ctr LUMC, Med Oncol, Leiden, Netherlands
[5] Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Amsterdam, Netherlands
[6] Maastricht Med Ctr, Med Oncol, Maastricht, Netherlands
[7] Zuyderland Med Ctr, Med Oncol, Heerlen, Netherlands
[8] Radboud Univ Nijmegen Med Ctr, Med Oncol Dept, Nijmegen, Netherlands
[9] Isala, Dept Med Oncol, Zwolle, Netherlands
[10] Netherlands Canc Inst, Antoni van Leeuwenhoek Hosp NKI AVL, Med Oncol Dept, Amsterdam, Netherlands
[11] Univ Med Ctr Groningen, Med Oncol, Groningen, Netherlands
[12] Leiden Univ Med Ctr LUMC, Dept Med Oncol, Leiden, Netherlands
[13] Medisch Spectrum Twente MST Radiol Examinat Only, Med Oncol, Enschede, Netherlands
[14] Med Ctr Leeuwarden, Dept Internal Med, Leeuwarden, Netherlands
[15] UMC Univ Med Ctr Utrecht, Med Oncol Dept, Utrecht, Netherlands
[16] Amphia Ziekenhuis, Med Oncol, Breda, Noord Brabant, Netherlands
[17] Erasmus MC, Med Oncol, Rotterdam, Netherlands
[18] Maxima Med Ctr Veldhoven, Internal Med, Veldhoven, Netherlands
关键词
D O I
10.1016/j.annonc.2020.08.1226
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1103P
引用
收藏
页码:S745 / S746
页数:2
相关论文
共 50 条
  • [1] Real-world survival of advanced melanoma patients treated with immunotherapy and targeted therapy
    Yu, Su-Yeon
    McKavanagh, Dan
    McPherson, Ian
    Walpole, Euan
    Hollingworth, Samantha
    Atkinson, Victoria
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 177 - 177
  • [2] Survival of advanced melanoma patients treated with immunotherapy and targeted therapy: A real-world study
    Yu, Su-Yeon
    Mckavanagh, Dan
    McPherson, Ian
    Walpole, Euan
    Atkinson, Victoria
    Hollingworth, Samantha
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (10) : 1371 - 1379
  • [3] Real-world treatment patterns and outcomes for patients with advanced melanoma treated with immunotherapy or targeted therapy
    Lee, Sejin
    Bennett, Antonia V.
    Zhou, Xi
    Warner, Allison Betof
    Trogdon, Justin G.
    Kent, Erin E.
    Lund, Jennifer L.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 (09) : 988 - 1000
  • [4] Long-term outcomes in patients with BRAF-mutant advanced melanoma: A real-world study
    Amin, A.
    Pavlick, A. C.
    Lee, C.
    Chou, E.
    Zhang, Y.
    Sakkal, L. A.
    Moser, J.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1415 - S1416
  • [5] Long-Term Survival in Patients With Advanced Melanoma
    van Not, Olivier J.
    van den Eertwegh, Alfons J. M.
    Jalving, Hilde
    Bloem, Manja
    Haanen, John B.
    van Rijn, Rozemarijn S.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    Blank, Christian U.
    Boers-Sonderen, Marye J.
    de Groot J. W. B., Jan Willem
    Hospers, Geke A. P.
    Kapiteijn, Ellen
    Leeneman, Brenda
    Piersma, D.
    Stevense-den Boer, Marion
    van der Veldt, Astrid A. M.
    Vreugdenhil G., Gerard
    Wouters, Michel W. J. M.
    Blokx, Willeke A. M.
    Suijkerbuijk, Karijn P. M.
    [J]. JAMA NETWORK OPEN, 2024, 7 (08)
  • [6] Real-world treatment patterns and overall survival in BRAF-mutant melanoma patients treated with immunotherapy or targeted therapy
    Atkins, Michael B.
    Julian, Cristina
    Secrest, Matthew H.
    Lee, Janet
    Abajo-Guijarro, Ana M.
    McKenna, Edward
    [J]. FUTURE ONCOLOGY, 2022, 18 (18) : 2233 - 2245
  • [7] LONG-TERM SURVIVAL OF PATIENTS WITH ADVANCED MELANOMA TREATED SECOND LINE WITH IPILIMUMAB
    Lee, D.
    Pericleous, L.
    Lebmeier, M.
    Winn, B.
    Batty, A.
    Nikoglou, T.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 370 - 370
  • [8] Treatment patterns and overall survival (OS) in patients with advanced BRAF mutant (mt) melanoma treated with immunotherapy and targeted therapy (TT) in a real-world setting
    Atkins, M. B.
    Julian, C.
    Secrest, M. H.
    Lee, J.
    Abajo, A. M.
    McKenna, E.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1446 - S1446
  • [9] Real-world long-term outcomes of advanced/metastatic NSCLC patients treated with EGFR TKIs in Nottinghamshire
    Lopez-Escola, C.
    Mengoli, K.
    Sheikh, O.
    Karim, S.
    Sadiq, M.
    [J]. LUNG CANCER, 2020, 139 : S62 - S62
  • [10] Real-world, long-term survival of incident patients with pulmonary arterial hypertension
    Marques-Alves, P.
    Baptista, R.
    Marinho da Silva, A.
    Pego, M.
    Castro, G.
    [J]. REVISTA PORTUGUESA DE PNEUMOLOGIA, 2017, 23 (03) : 124 - 131